- Home
- BHAT vs IMNN Comparison
BHAT vs IMNN Comparison
Compare BHAT & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHAT
- IMNN
- Stock Information
- Founded
- BHAT 2010
- IMNN 1982
- Country
- BHAT China
- IMNN United States
- Employees
- BHAT N/A
- IMNN N/A
- Industry
- BHAT Recreational Games/Products/Toys
- IMNN Biotechnology: Pharmaceutical Preparations
- Sector
- BHAT Consumer Discretionary
- IMNN Health Care
- Exchange
- BHAT Nasdaq
- IMNN Nasdaq
- Market Cap
- BHAT 12.3M
- IMNN 12.1M
- IPO Year
- BHAT 2019
- IMNN 1985
- Fundamental
- Price
- BHAT $1.77
- IMNN $5.42
- Analyst Decision
- BHAT
- IMNN Buy
- Analyst Count
- BHAT 0
- IMNN 2
- Target Price
- BHAT N/A
- IMNN $182.61
- AVG Volume (30 Days)
- BHAT 1.1M
- IMNN 54.7K
- Earning Date
- BHAT 04-30-2025
- IMNN 11-06-2025
- Dividend Yield
- BHAT N/A
- IMNN N/A
- EPS Growth
- BHAT N/A
- IMNN N/A
- EPS
- BHAT N/A
- IMNN N/A
- Revenue
- BHAT $18,724,190.00
- IMNN N/A
- Revenue This Year
- BHAT N/A
- IMNN N/A
- Revenue Next Year
- BHAT N/A
- IMNN N/A
- P/E Ratio
- BHAT N/A
- IMNN N/A
- Revenue Growth
- BHAT N/A
- IMNN N/A
- 52 Week Low
- BHAT $1.51
- IMNN $4.83
- 52 Week High
- BHAT $45.00
- IMNN $41.22
- Technical
- Relative Strength Index (RSI)
- BHAT 54.51
- IMNN 48.06
- Support Level
- BHAT $1.62
- IMNN N/A
- Resistance Level
- BHAT $2.02
- IMNN $5.89
- Average True Range (ATR)
- BHAT 0.17
- IMNN 0.30
- MACD
- BHAT 0.01
- IMNN -0.15
- Stochastic Oscillator
- BHAT 44.44
- IMNN 84.82
About BHAT Blue Hat Interactive Entertainment Technology
Blue Hat Interactive Entertainment Technology is focused on commodity trading, including chemicals, jewelry, and precious metals such as gold. It operates a gold and diamond trading and supply chain business. Its business model encompasses physical gold trading, diamond trading, gold derivatives trading, and the development of AI-enabled trading platforms. Its segments include Diamond trading, Commodity trading, Information service, Interactive toys - animation series, and Interactive toys - game series. It derives revenue from Diamond trading. The majority of its revenues are generated in PRC.
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).